The US tax changes throw into doubt the agreed £32bn takeover of Shire by AbbVie and make it less likely Pfizer will revive its interest in AstraZeneca
Source: Companies
Author
Harry Joiner
“… a dominant recruiter in the client-side multichannel ecommerce space …” — SearchEngineWatch.com